Omadacycline for the treatment of severe pneumonia caused by Chlamydia psittaci complicated with acute respiratory distress syndrome during the COVID-19 pandemic
IntroductionChlamydia psittaci infection in humans is a rare cause that mainly present as community-acquired pneumonia. Severe Chlamydia psittaci pneumonia can lead to acute respiratory distress syndrome (ARDS), septic shock, or multiple organ dysfunction with a mortality rate of 15%–20% before accu...
Main Authors: | Dao-Xin Wang, Ling-Xi Xiao, Xin-Yu Deng, Wang Deng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-01-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2023.1207534/full |
Similar Items
-
Omadacycline for the Treatment of Severe Chlamydia psittaci Pneumonia Complicated with Guillain-Barre Syndrome
by: Wang J, et al.
Published: (2024-01-01) -
Application of metagenomic next-generation sequencing in the diagnosis of severe pneumonia caused by Chlamydia psittaci
by: Huan-huan Wu, et al.
Published: (2021-09-01) -
Clinical analysis of severe Chlamydia psittaci pneumonia: Case series study
by: Zheng Xi, et al.
Published: (2023-09-01) -
Clinical Symptoms and Outcomes of Severe Pneumonia Caused by Chlamydia psittaci in Southwest China
by: Fuxun Yang, et al.
Published: (2022-01-01) -
Atypical pneumonia caused by Chlamydia psittaci during the COVID-19 pandemic
by: Qiaoqiao Yin, et al.
Published: (2022-09-01)